
Humira: An injected biologic for moderate to severe plaque psoriasis. It blocks TNF, one of the main inflammation signals behind psoriasis, and is usually given as a shot under the skin every other week. Zoryve: A once-daily steroid-free cream for psoriasis, eczema and seborrheic dermatitis. It has no boxed warning and no limit on how long or how much you use it, which is unusual.


Choose for moderate to severe psoriasis or hidradenitis suppurativa — the first approved biologic for HS, now with cheaper biosimilars.
Choose for psoriasis, eczema or seborrheic dermatitis when you want a once-daily non-steroid with no limit on time or area.
Can you take them together?
Zoryve can be used on remaining plaques while on Humira, including the face and folds.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.











Binds TNF: Captures an immune messenger that promotes inflammation. Reduces inflammatory signaling: TNF has less ability to activate its receptors. Lets inflamed skin settle: Conditions such as psoriasis can improve over time.
Adalimumab binds TNF-alpha and inhibits its interaction with p55/p75 TNF receptors. This image focuses on skin inflammation; Humira also has other indications.

Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Redness, scaling, and itch can improve.
PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.
Adults are not dosed by body weight. You start with a larger loading dose to get levels up fast, then settle into an every-other-week rhythm.
Starting dose: 80 mg on day one, as one 80 mg injection or two 40 mg injections at different spots.
One week later: 40 mg.
Usual dose: 40 mg every other week, the same day of the week each time.
If it stops working: Some people move to weekly injections, others switch drugs. The prescriber's call.
Other conditions: Hidradenitis suppurativa uses a heavier loading dose and weekly maintenance, so do not assume a friend's schedule matches yours.
How long: Long term, with no set course length. It continues while it works and is tolerated.
When to Apply: Once a day, at a time you will remember. A thin layer over the affected skin, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts. Moisturizer and sunscreen can go on top once it has absorbed. For the foam, part the hair and apply to the scalp rather than the hair.
How to Start: Once daily from day one, on every affected area. No build-up period, no strength to work through. The common mistake is treating only the worst patches, which makes the result look worse than it is.
If It Irritates: Stinging or mild burning where you apply it settles within a week or two, and moisturizing beforehand helps. Loose stools, headache or feeling slightly sick in the first weeks is a known, usually mild effect of the drug — tell your doctor if it does not pass.
If It's Not Working: Give it 8 weeks of daily use, though itch often eases much sooner. If plaques are unchanged at 8 weeks, the options are a strong steroid for the thickest areas while keeping roflumilast on the rest, adding a vitamin D cream, or moving to light treatment or a systemic medicine. Twice a day does not help.
Any time of day, but pick a set day of the week and keep to it. Every other week is easy to lose track of, so set a phone reminder on day one.
Take the pen or syringe out of the fridge 15 to 30 minutes before injecting. Cold liquid stings more. Do not warm it in the microwave or hot water.
Inject into the front of the thigh or the belly, at least two inches from the navel. Rotate the spot each time, and avoid skin that is bruised, red, hard, tender or scarred. Never inject through a plaque. A nurse or pharmacist should train you in person for the first dose. Used pens go in a sharps container, never the household bin.
Inject as soon as you remember, then return to your original schedule rather than shifting future doses. Never inject two doses to catch up. If you have missed more than one dose, call the prescriber before restarting — long gaps can blunt how well it works.
Everyone is screened for tuberculosis before the first dose — a skin test or TB blood test, often with a chest X-ray. TNF blockers can wake a dormant TB infection, so a positive screen is treated first and adalimumab waits until that treatment is under way. Testing is often repeated yearly, or sooner if you live somewhere TB is common.
Hepatitis B and C are checked too, because hepatitis B can reactivate when the immune signal is blocked.
After that there is no fixed blood test schedule like methotrexate's. Many doctors check a blood count and liver tests occasionally. Most monitoring is clinical — how the skin looks, and whether you are getting more infections than usual.
Skin should be checked periodically, because TNF blockers are linked to a small increase in skin cancer. The label also carries a boxed warning about serious infections and about lymphoma and other cancers, based mostly on rare cases in children and young adults. The absolute risk is low, but it is why this prescription gets regular review.
No routine blood tests, no boxed warning, no limit on how much body surface you treat, no maximum duration.
What is worth watching has nothing to do with skin. The oral form causes diarrhea, nausea, appetite loss and weight loss in a meaningful number of people, and has been linked to low mood and, rarely, suicidal thoughts. The cream and foam give much lower blood levels, so these are far less common — but they are on the label and your doctor will ask. If you lose weight without trying, or your mood drops, say so.
Otherwise monitoring is a review of whether it is working, around 8 weeks at first. Your doctor will check your history for liver problems, since severe liver impairment rules it out.
Approximate windows, not promises.
First few minutesThe injection: A sting for a few seconds. Injection site reactions, if they happen, show up in the first weeks.
First few minutesApplying it: Once a day. Possible stinging where you apply it, which usually settles.
Weeks 1 to 4Starting: Itching often eases before the plaques look different, and some people see the scale thin early.
Weeks 4 to 12Working: Plaques flatten, scale lifts and redness fades from the middle outward. Most of the visible change happens here. Psoriatic arthritis improves on a similar timeline, and hidradenitis suppurativa settles to fewer painful lumps on its own heavier schedule.
Week 16Judge it here: The point the trials measured. Most people reached at least a 75 percent improvement in skin involvement and severity, and a smaller share cleared almost completely.
Months 6 to 12Nails: The slowest, because a nail takes months to grow out. Pitting and lifting improve well after the skin has settled.
After the first yearLong term: Most people who respond keep responding.
Week 1Adjusting: A few people get diarrhea, headache or mild nausea. These come from the drug rather than the skin, and are far less common with the cream than the oral version.
Weeks 1 to 2First change: Itch improves first. In seborrheic dermatitis, flaking and redness often start easing here too.
Weeks 4 to 8Working: Plaques flatten, scale drops away and redness fades. Week 8 is the fair point to judge plaque psoriasis; eczema and seborrheic dermatitis declare themselves around four weeks. Thinner plaques respond faster.
Folds, face and eyelidsWhere it stands out: These sites absorb steroids quickly and thin fast, so a once-daily option with no time limit changes how they are managed.
After clearingHolding: No thinning, so no reason to stop once skin is clear. Many people continue daily; some drop to a few times a week.
Sorted by what to do about them.
The list price is very high, tens of thousands of dollars a year. Almost nobody pays that. What you pay depends on your insurance, and getting there takes paperwork.
Prior authorization is close to universal. Most plans require you to have tried and failed something cheaper first — phototherapy, methotrexate or another systemic drug — and they want records to prove it.
Biosimilars changed the picture. Several have been sold in the United States since 2023, some at much lower list prices. Which one you get is usually decided by your plan's formulary, not your dermatologist, and plans switch year to year. A switch is a paperwork event, not a medical downgrade, though you may need retraining on a different pen.
Manufacturer copay cards can bring the cost down to very little with commercial insurance. By law they cannot be used with Medicare or Medicaid. For those plans, or with no insurance, manufacturer and foundation assistance programs are the usual route, and their rules change often.
This is the main reason people do not end up on it. Roflumilast is brand only with no generic, and a tube runs to several hundred dollars or more. Generic steroid creams cost a small fraction of that.
A prior authorization is close to routine. Most plans want to see that a topical steroid was tried and either failed or is not appropriate — the fold, face and eyelid argument usually succeeds, because those are exactly the places long-term steroid use causes harm. Some plans also want a vitamin D cream tried first. Denials are common on the first attempt and often overturned on appeal, so push back.
The manufacturer runs a copay program that can cut the cost substantially with commercial insurance, plus patient assistance for people who qualify. Terms change often. People on government insurance generally cannot use copay cards, which is a real gap.
One practical note: cost is per tube and psoriasis treatment is open-ended, so ask about the largest tube your plan will cover — the price per gram is usually better.
A large protein grown in living cells rather than a factory chemical. That is why it is injected, and why it lives in the fridge.
A sharp sting for a few seconds. Letting it warm to room temperature first makes a real difference, and citrate-free versions sting less than the original.
Some change by 4 weeks, and about 16 weeks before you judge it fairly. If nothing has happened by then, talk about switching.
Yes, apart from live ones. The flu shot, COVID, pneumonia vaccines and Shingrix are fine and usually recommended. Have live vaccines before you start.
A simple cold is usually not a reason to skip a dose. Anything with a fever, or needing antibiotics, should be checked with the prescriber first.
It must be shown to have no clinically meaningful difference from the original. The pen changes; what is inside does the same job.
No. It blocks an enzyme called PDE4 inside inflammatory cells. It does not thin skin, which is why it can go on the face, eyelids and folds without a time limit.
There is no fixed maximum. The rule about stopping after a few weeks comes from steroid creams. Long-term daily use with regular review is normal.
Once daily is what the trials tested. Twice does not clear skin faster and makes stomach side effects more likely.
Usually not. Diarrhea, nausea and headache are listed because they can happen, and are common with the oral version used for lung disease. Blood levels from the cream and foam are much lower.
The drug is the same. The foam lets it spread through hair and over the scalp, and it is the form used for seborrheic dermatitis. The 0.3% cream is for psoriasis and the 0.15% cream for eczema.
Clearing inflammation often leaves a dark or pale patch. Not active disease, and it fades over months. It shows up more on deeper skin tones.
A common approach — a strong steroid for the thickest patches, roflumilast for the face, folds and the rest. Plan it with your doctor rather than layering both on one spot.